Eleven of the 25 (44%) ER-positive primary tumor samples were associated with ESR1-negative DTCs, while 2 of the 4 (50%) ER-negative tumors had ER-positive DTCs (Fig. 5c). Here, ESR1 is linked to neoplasm.